Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3346/jkms.2021.36.e157 http://scihub22266oqcxt.onion/10.3346/jkms.2021.36.e157 34060263!8167408!34060263     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34060263&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Korean+Med+Sci 2021 ; 36 (21): e157 Nephropedia Template TP {{tp|p=34060263|t=2021. Antibody Responses One Year after Mild SARS-CoV-2 Infection |pdf=|usr=}}{{34060263}} gab.com Text Antibody Responses One Year after Mild SARS-CoV-2 Infection JO: J Korean Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=34060263 #FOAvip Understanding the long-term kinetics of antibodies in coronavirus disease 2019 (COVID-19) is essential in interpreting serosurvey data. We investigated the antibody response one year after infection in 52 mildly symptomatic patients with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, using three commercial immunoassays and a surrogate virus neutralization test (sVNT) kit. Anti-N pan-immunoglobulin (Ig), anti-S IgG, and anti-S1 IgG were detected in 43 (82.7%), 44 (84.6%), and 30 (57.7%), respectively. In 49 (94.2%), the antibody could be detected by either anti-N pan-Ig or anti-S IgG assay. In the sVNT, 30 (57.7%) had positive neutralizing activity. Despite waning immunity, SARS-CoV-2 antibodies can be detected up to one year after infection, even in mild COVID-19 patients. Twit Text FOAVip Antibody Responses One Year after Mild SARS-CoV-2 Infection ????J Korean Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=34060263 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34060263 #FOAvip English Wikipedia <ref>{{Cite pmid|34060263}}</ref> Antibody Responses One Year after Mild SARS-CoV-2 Infection #MMPMID34060263 Choe PG; Kim KH; Kang CK; Suh HJ; Kang E; Lee SY; Kim NJ; Yi J; Park WB; Oh MD J Korean Med Sci 2021[May]; 36 (21): e157 PMID34060263show ga Understanding the long-term kinetics of antibodies in coronavirus disease 2019 (COVID-19) is essential in interpreting serosurvey data. We investigated the antibody response one year after infection in 52 mildly symptomatic patients with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, using three commercial immunoassays and a surrogate virus neutralization test (sVNT) kit. Anti-N pan-immunoglobulin (Ig), anti-S IgG, and anti-S1 IgG were detected in 43 (82.7%), 44 (84.6%), and 30 (57.7%), respectively. In 49 (94.2%), the antibody could be detected by either anti-N pan-Ig or anti-S IgG assay. In the sVNT, 30 (57.7%) had positive neutralizing activity. Despite waning immunity, SARS-CoV-2 antibodies can be detected up to one year after infection, even in mild COVID-19 patients. |Adult[MESH] |Antibodies, Viral/*blood[MESH] |COVID-19/*immunology[MESH] |Cross-Sectional Studies[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Neutralization Tests[MESH] |Reagent Kits, Diagnostic[MESH] |SARS-CoV-2/*immunology[MESH] |Time Factors[MESH]Antibody Responses One Year after Mild SARS-CoV-2 Infection (epmc).pdf DeepDyve Pubget Overpricing